Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Merck & Co Inc (NYSE:MRK)

62.41
Delayed Data
As of Sep 30
 +0.50 / +0.81%
Today’s Change
47.97
Today|||52-Week Range
64.00
+18.16%
Year-to-Date
3 Top Healthcare Stocks to Buy Now
Sep 30 / MotleyFool.com - Paid Partner Content
Eli Lilly Stock Upgraded: What You Need to Know
Sep 27 / MotleyFool.com - Paid Partner Content
Deutsche Bank's Losses Affecting the Market on Thursday
Sep 29 / GuruFocus News - Paid Partner Content
Amgen/UCB's BLA for Osteoporosis Drug Accepted in the U.S.
Sep 27 / Zacks.com - Paid Partner Content
Stocks Higher With OPEC Agreement
Sep 29 / GuruFocus News - Paid Partner Content
Bristol, Nektar Research Pact Aims to Boost Efficacy of Cancer Immunotherapy
Sep 27 / TheStreet.com - Paid Partner Content
Gilead Sciences Stock Downgraded: 3 Things You Need to Know
Sep 28 / MotleyFool.com - Paid Partner Content
Wall Street Sells Off on Worries Over Clinton-Trump Showdown
Sep 26 / TheStreet.com - Paid Partner Content
Investors Reward Merck Despite Flat Revenue Growth
Sep 27 / GuruFocus News - Paid Partner Content
Stocks Fall Ahead of Clinton-Trump Debate, Crude Rallies
Sep 26 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close61.91
Today’s open61.89
Day’s range61.86 - 62.73
Volume13,605,282
Average volume (3 months)9,635,643
Market cap$171.2B
Dividend yield2.95%
Data as of 4:01pm ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)-61.67%
Earnings growth (this year)+4.31%
Earnings growth (next 5 years)+6.10%
Revenue growth (last year)-7.92%
P/E ratio34.3
Price/Sales3.87
Price/Book3.85

Competitors

 Today’s
change
Today’s
% change
NVSNovartis-0.29-0.37%
PFEPfizer+0.55+1.65%
GSKGlaxoSmithKline+0.23+0.54%
ABBVAbbVie+0.25+0.40%
Data as of 4:02pm ET, 09/30/2016

Financials

Next reporting dateOctober 25, 2016
EPS forecast (this quarter)$0.98
Annual revenue (last year)$38.8B
Annual profit (last year)$4.4B
Net profit margin11.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman, President &
Chief Executive Officer
Kenneth C. Frazier
Chief Financial Officer &
Executive Vice President
Robert M. Davis
Corporate headquarters
Kenilworth, New Jersey

Forecasts

Search for Jobs